Who makes Shz QIV 0.5 mL, 2 doses?

Shz QIV 0.5 mL, 2 doses is developed by Sanofi Pasteur, a Sanofi Company.

What development phase is Shz QIV 0.5 mL, 2 doses in?

Shz QIV 0.5 mL, 2 doses is in Phase 1.

Last reviewed 2026-05-14 · How we verify

Shz QIV 0.5 mL, 2 doses

Sanofi Pasteur, a Sanofi Company · Phase 1 active Biologic

At a glance

Generic name	Shz QIV 0.5 mL, 2 doses
Sponsor	Sanofi Pasteur, a Sanofi Company
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age (PHASE3)
Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Shz QIV 0.5 mL, 2 doses CI brief — competitive landscape report
Shz QIV 0.5 mL, 2 doses updates RSS · CI watch RSS
Sanofi Pasteur, a Sanofi Company portfolio CI